EKO International Corp. announced the appointment of Dr. Paul Ziemer as Director of the company. In 2009 Dr. Ziemer began the development of a pain management and wound treatment product with a team from Canada and China.

In 2012 the product received full health Canada and FDA regulatory approvals along with ISO certification. In 2011 Dr. Ziemer also began working with FREMs clinically and has been developing the model for the most efficient patient delivery of FREMs treatments Dr. Ziemer manages NeuroVasc Clinical Inc.in partnership with EKO.